Process / pipelineVirus neutralization serology
Plaque Reduction Neutralization Test — PRNT
The Plaque Reduction Neutralization Test (PRNT) is a quantitative cell-based serological assay used in veterinary and human virology to measure the ability of antibodies in a serum sample to neutralize a live virus. By counting visible plaques — areas of cell destruction on a monolayer — the method determines the serum titer at which viral infectivity is reduced by 50% or 90%, making it the gold-standard technique for detecting and quantifying neutralizing antibodies against many RNA and DNA viruses.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Dulbecco, R., & Vogt, M. (1954). Plaque formation and isolation of pure lines with poliomyelitis viruses. Journal of Experimental Medicine, 99(2), 167–182. DOI: 10.1084/jem.99.2.167 ↗
- Roehrig, J. T., Hombach, J., & Barrett, A. D. T. (2008). Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunology, 21(2), 123–132. DOI: 10.1089/vim.2008.0007 ↗